Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic.
Laidlaw SM. et al, (2025), Microbiology spectrum
Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2.
Cornish K. et al, (2024), Open biology, 14
SARS-CoV-2 infection enhancement by Amphotericin B: Implications for disease management
Nguyen D. et al, (2024)
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Barnes E. et al, (2023), Nature Medicine, 29, 1760 - 1774
Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
Brewitz L. et al, (2023), Journal of Medicinal Chemistry, 66, 2663 - 2680
A prototype lateral flow assay for detection of orthopoxviruses.
Ulaeto DO. et al, (2022), The Lancet. Infectious diseases, 22, 1279 - 1280
Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.
Harvala H. et al, (2022), Transfusion, 62, 1347 - 1354
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.
Guimond SE. et al, (2022), ACS central science, 8, 527 - 545